Earnings Reportpositive
Earnings Report
- Company
- Royalty Pharma plc (RPRX)
Other upcoming events for RPRX
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermitte
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivati
Patent ExpiryPatent/Exclusivity Expiry: AMVUTTRA
Patent ExpiryPatent/Exclusivity Expiry: ERLEADA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.